
About Allergy Free
Allergy Free is a publicly listed company based in Mumbai (India) founded in 2018. Allergy education and management services in healthcare by Sanofi. The company has 2,191 employees. Its website allergyfree.co.in draws about 14 thousand monthly visits. Its Indian entity Sanofi India Limited reported revenue of ₹1,857 Cr. Allergy Free offers products and services including Allergy Information Services and Educational Resources. Its focus areas include Consumer Health, Educational Resources, Information Distribution and Pharmaceuticals.
Company details
Allergies are discussed extensively on the website, covering symptoms, prevention strategies, and side effects across various types such as outdoor, indoor, and childhood allergies. Information on pollution-related risks in India and comparisons with conditions like COVID-19 is included to clarify distinctions. Management techniques, including lifestyle adjustments and diagnostic tools, are outlined to aid in symptom control, while myths and facts are addressed to promote accurate understanding. Resources like FAQs and downloads are made available for comprehensive support.
- Headquarters Mumbai, India
- Employees 2,191
- Stage Public
- SectorsHealthcare
- Website allergyfree.co.in
- Social X Facebook Instagram YouTube
- Legal Name Sanofi India Ltd
- Date of Incorporation 02 May, 1956
- Jurisdiction Mumbai, Maharashtra, India
- Market Cap₹7,375 Cr
SANOFI · NSE
- Share Price₹3,206.10
+0.11% today
- Revenue₹2,013 Cr
Dec 2024 · +0.9% YoY
- EBITDA₹453 Cr
Margin 22.5%
- Net Profit₹442 Cr
Dec 2024 · -24.9% YoY
- P/E (TTM)21.0x
P/B 9.3x
- ROE47.1%
ROCE 48.0%
- Debt / Equity0.02
Interest cover 0.4x
- Employee Count2,191
Associated legal entities of Allergy Free
Allergy Free operates through Sanofi India Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sanofi India Limited Listed CIN L24239MH1956PLC009794 | Active | 02 May 1956 | Mumbai, Maharashtra | ₹1,857 Cr | 2,191 | 11 | View details |
Products & Services of Allergy Free
Allergy Free offers a comprehensive portfolio of products and services, including Allergy Information Services and Educational Resources.
Information on allergy symptoms, prevention, and management is offered to assist in handling reactions effectively.
Downloads and tips on allergy myths, facts, and treatments are provided to support better understanding and control of allergies.
Apps and channels of Allergy Free
its YouTube channel AllergyFree India has 2.17K subscribers and 10 videos.
Videos from Allergy Free
The most watched videos on Allergy Free's YouTube channel, AllergyFree India (2.17K subscribers). Click a video to play it here.
More on AllergyFree India.
Board of directors of Sanofi India Limited (Allergy Free)
Sanofi India Limited is the primary company behind Allergy Free. The board of Sanofi India Limited currently have 9 directors; the longest-serving is Rahul Bhatnagar, appointed in 2020. 45 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rahul Bhatnagar DIN 07268064 | Director | 29 Jul 2020 | 6 yrs 3 mo | Sanofi India Limited |
| Vaibhav Vinayak Karandikar DIN 09049375 | Director | 23 Feb 2021 | 5 yrs 8 mo | Sanofi India Limited |
| Rachid Ayari DIN 10408699 | Whole-time director | 01 Dec 2023 | 2 yrs 11 mo | Sanofi India Limited |
| Eric Yves Mansion DIN 10654588 | Director | 03 Jun 2024 | 2 yrs 5 mo | Sanofi India Limited |
| Mahadev Keshav Gawade DIN 11231316 | Whole-time director | 11 Aug 2025 | 1 yr 3 mo | Sanofi India Limited |
| Deepak Arora DIN 07495638 | Managing Director | 27 Oct 2025 | 1 yr | Sanofi India Limited |
| Sudipta Chakraborty DIN 07166912 | Whole-Time Director | 01 Mar 2026 | 8 mo | Sanofi India Limited |
| Siraj Azmat Chaudhry DIN 00161853 | Director | 01 Apr 2026 | 7 mo | Sanofi India Limited |
| Rajani Kesari DIN 02384170 | Director | 01 Apr 2026 | 7 mo | Sanofi India Limited |
IPO & Listings of Allergy Free
Allergy Free is a publicly listed company on the NSE with ticker symbol SANOFI in India, operating in the Pharmaceuticals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: SANOFI
- Listed entitySanofi India Limited
- Exchange sectorPharmaceuticals
Financials of Allergy Free
Exchange-reported figures of Sanofi India Limited, the listed company behind Allergy Free (NSE: SANOFI).
Financial Highlights
Dec 2024 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | Dec 2024 | Dec 2023 |
|---|---|---|
| Income statement | ||
| Revenue | 2,013 | 1,996 |
| Revenue growth | +0.9% | - |
| EBITDA | 453 | 488 |
| EBITDA margin | +22.5% | +24.4% |
| Profit before tax | 531 | 767 |
| Net profit | 442 | 589 |
| Net profit margin | +22.0% | +29.5% |
| EPS (₹) | 179.70 | 262.13 |
| Balance sheet | ||
| Cash flow | ||
| Particulars | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 515 | 524 | 464 | 511 | 469 | 491 | 515 | 521 |
| Revenue growth (YoY) | +9.7% | +6.8% | -10.0% | -2.0% | - | - | - | - |
| Other income | 13.90 | 2.30 | 39.80 | 68.10 | 77.40 | 81.90 | 57.40 | 101 |
| EBITDA | 118 | 120 | 96.70 | 110 | 99.60 | 114 | 122 | 153 |
| EBITDA margin | +23.0% | +22.8% | +20.9% | +21.6% | +21.2% | +23.1% | +23.6% | +29.3% |
| Depreciation | 9.60 | 9.00 | 9.00 | 9.10 | 9.30 | 9.20 | 9.10 | 8.90 |
| Interest | 0.40 | 0.40 | 0.40 | 0.30 | 0.40 | 0.30 | 0.70 | 0.30 |
| Profit before tax | 122 | 113 | 127 | 169 | 167 | 186 | 169 | 244 |
| Tax | 30.90 | 30.40 | 23.90 | 32.50 | 29.60 | 34.00 | 46.30 | 53.90 |
| Net profit | 91.30 | 82.20 | 103 | 137 | 138 | 152 | 123 | 190 |
| EPS (₹) | 39.64 | 35.69 | 44.81 | 59.31 | 59.79 | 65.95 | 53.37 | 0.00 |
| Metrics | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,837 | 2,013 | 2,851 | 2,770 | 2,957 | 2,902 | 3,071 |
| Revenue growth | -8.7% | -29.4% | +2.9% | -6.3% | +1.9% | -5.5% | - |
| EBITDA | 464 | 453 | 804 | 704 | 762 | 671 | 606 |
| EBITDA margin | +25.3% | +22.5% | +28.2% | +25.4% | +25.8% | +23.1% | +19.7% |
| Profit before tax | 445 | 531 | 846 | 864 | 1,258 | 677 | 600 |
| Net profit | 346 | 442 | 591 | 526 | 581 | 508 | 452 |
| Net profit margin | +18.9% | +22.0% | +20.7% | +19.0% | +19.7% | +17.5% | +14.7% |
| EPS (₹) | 142.04 | 179.78 | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
| Balance sheet | |||||||
| Cash flow | |||||||
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 492 | 438 | 472 | 420 | 475 | 406 | 536 | 515 |
| Revenue growth (YoY) | +3.4% | +7.7% | -11.9% | -18.5% | -9.3% | -12.3% | - | - |
| Other income | 5.50 | 6.20 | 4.40 | 2.80 | 4.90 | 8.70 | 3.30 | 13.90 |
| Total expenses | 330 | 322 | 330 | 330 | 368 | 311 | 364 | 397 |
| EBITDA | 161 | 115 | 143 | 90.30 | 107 | 94.90 | 172 | 118 |
| EBITDA margin | +32.8% | +26.3% | +30.2% | +21.5% | +22.5% | +23.4% | +32.1% | +23.0% |
| Depreciation | 8.80 | 8.90 | 9.00 | 9.50 | 9.10 | 9.10 | 9.60 | 9.60 |
| Interest | 0.20 | 0.30 | 0.30 | 0.60 | 0.40 | 0.40 | 0.30 | 0.40 |
| Profit before tax | 158 | 112 | 138 | 83.00 | 102 | 94.10 | 165 | 122 |
| Tax | 41.00 | 28.80 | 35.30 | 21.30 | 26.30 | 24.60 | 45.80 | 30.90 |
Financial Statements
| Particulars | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 515 | 524 | 464 | 511 | 469 | 491 | 515 | 521 |
| Revenue growth (YoY) | +9.7% | +6.8% | -10.0% | -2.0% | - | - | - | - |
| Other income | 13.90 | 2.30 | 39.80 | 68.10 | 77.40 | 81.90 | 57.40 | 101 |
| EBITDA | 118 | 120 | 96.70 | 110 | 99.60 | 114 | 122 | 153 |
| EBITDA margin | +23.0% | +22.8% | +20.9% | +21.6% | +21.2% | +23.1% | +23.6% | +29.3% |
| Depreciation | 9.60 | 9.00 | 9.00 | 9.10 | 9.30 | 9.20 | 9.10 | 8.90 |
| Interest | 0.40 | 0.40 | 0.40 | 0.30 | 0.40 | 0.30 | 0.70 | 0.30 |
| Profit before tax | 122 | 113 | 127 | 169 | 167 | 186 | 169 | 244 |
| Tax | 30.90 | 30.40 | 23.90 | 32.50 | 29.60 | 34.00 | 46.30 | 53.90 |
| Net profit | 91.30 | 82.20 | 103 | 137 | 138 | 152 | 123 | 190 |
| EPS (₹) | 39.64 | 35.69 | 44.81 | 59.31 | 59.79 | 65.95 | 53.37 | 0.00 |
| Particulars | Dec 2024 | Dec 2023 |
|---|---|---|
| Revenue | 2,013 | 1,996 |
| Revenue growth | +0.9% | - |
| Other income | 116 | 317 |
| Total expenses | 1,560 | 1,508 |
| Employee cost | 240 | 281 |
| EBITDA | 453 | 488 |
| EBITDA margin | +22.5% | +24.4% |
| Depreciation | 36.70 | 36.50 |
| Interest | 1.50 | 1.70 |
| Profit before tax | 531 | 767 |
| Tax | 118 | 164 |
| Net profit | 442 | 589 |
| Net profit margin | +22.0% | +29.5% |
| EPS (₹) | 179.70 | 262.13 |
| Particulars | Dec 2024 | Dec 2023 |
|---|---|---|
| Growth | ||
| Sales growth | +0.9% | - |
| EBITDA growth | -7.1% | - |
| PBT growth | -30.8% | +9997.0% |
| Net income growth | -24.9% | - |
| Profitability & leverage | ||
| Net income margin | +20.5% | +30.2% |
| Return on capital employed | +48.0% | +48.1% |
| Return on net worth | +47.1% | +58.0% |
| Debt / equity | 0.02 | 0.02 |
| Long-term debt / equity | 0.01 | 0.01 |
| Interest cover | 0.36 | 0.38 |
| Efficiency & per share | ||
| Fixed asset turnover | 3.65 | 3.67 |
| Inventory turnover | 3.46 | 3.01 |
| Debtors turnover | 11.13 | 15.16 |
| EPS (₹) | 179.70 | 262.13 |
| Dividend per share (₹) | 117.00 | 167.00 |
| Book value per share (₹) | 374.17 | 441.39 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 492 | 438 | 472 | 420 | 475 | 406 | 536 | 515 |
| Revenue growth (YoY) | +3.4% | +7.7% | -11.9% | -18.5% | -9.3% | -12.3% | - | - |
| Other income | 5.50 | 6.20 | 4.40 | 2.80 | 4.90 | 8.70 | 3.30 | 13.90 |
| Total expenses | 330 | 322 | 330 | 330 | 368 | 311 | 364 | 397 |
| EBITDA | 161 | 115 | 143 | 90.30 | 107 | 94.90 | 172 | 118 |
| EBITDA margin | +32.8% | +26.3% | +30.2% | +21.5% | +22.5% | +23.4% | +32.1% | +23.0% |
| Depreciation | 8.80 | 8.90 | 9.00 | 9.50 | 9.10 | 9.10 | 9.60 | 9.60 |
| Interest | 0.20 | 0.30 | 0.30 | 0.60 | 0.40 | 0.40 | 0.30 | 0.40 |
| Profit before tax | 158 | 112 | 138 | 83.00 | 102 | 94.10 | 165 | 122 |
| Tax | 41.00 | 28.80 | 35.30 | 21.30 | 26.30 | 24.60 | 45.80 | 30.90 |
| Particulars | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,837 | 2,013 | 2,851 | 2,770 | 2,957 | 2,902 | 3,071 |
| Revenue growth | -8.7% | -29.4% | +2.9% | -6.3% | +1.9% | -5.5% | - |
| Other income | 19.70 | 116 | 83.10 | 204 | 564 | 89.80 | 94.10 |
| Total expenses | 1,373 | 1,560 | 2,047 | 2,066 | 2,194 | 2,230 | 2,465 |
| Employee cost | 185 | 240 | 371 | 406 | 434 | 461 | 450 |
| EBITDA | 464 | 453 | 804 | 704 | 762 | 671 | 606 |
| EBITDA margin | +25.3% | +22.5% | +28.2% | +25.4% | +25.8% | +23.1% | +19.7% |
| Depreciation | 37.30 | 36.70 | 39.60 | 41.90 | 66.70 | 82.20 | 99.90 |
| Interest | 1.70 | 1.50 | 1.70 | 1.70 | 1.80 | 1.80 | 0.30 |
| Profit before tax | 445 | 531 | 846 | 864 | 1,258 | 677 | 600 |
| Tax | 118 | 118 | 243 | 244 | 313 | 200 | 186 |
| Net profit | 346 | 442 | 591 | 526 | 581 | 508 | 452 |
| Net profit margin | +18.9% | +22.0% | +20.7% | +19.0% | +19.7% | +17.5% | +14.7% |
| EPS (₹) | 142.04 | 179.78 | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
| Particulars | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -8.7% | -29.4% | +2.9% | -6.3% | +1.9% | -5.5% | - |
| EBITDA growth | +2.4% | -43.6% | +14.1% | -7.6% | +13.6% | +10.8% | - |
| PBT growth | -16.3% | -37.2% | -2.1% | -31.3% | +85.7% | +12.9% | -1.6% |
| Net income growth | -21.7% | -25.1% | +12.3% | -9.5% | +14.3% | +12.4% | - |
| Revenue CAGR (3Y) | -12.8% | -12.0% | -0.6% | -3.4% | +2.2% | +5.7% | +9.1% |
| EBITDA CAGR (3Y) | -13.0% | -15.9% | +6.2% | +5.1% | +6.9% | +7.7% | +4.2% |
| Profitability & leverage | |||||||
| Net income margin | +17.8% | +20.5% | +21.2% | +22.4% | +31.9% | +16.5% | +13.5% |
| Return on capital employed | +54.2% | +48.4% | +70.6% | +40.3% | +33.8% | +28.9% | +27.8% |
| Return on net worth | +40.6% | +47.2% | +52.7% | +30.1% | +26.8% | +20.9% | +19.4% |
| Debt / equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 |
| Long-term debt / equity | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Interest cover | 0.40 | 0.36 | 0.22 | 0.26 | 0.26 | 0.31 | 0.06 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.23 | 3.65 | 5.31 | 5.14 | 4.23 | 3.48 | 3.28 |
| Inventory turnover | 4.53 | 3.46 | 5.32 | 6.92 | 7.78 | 6.93 | 6.45 |
| Debtors turnover | 9.04 | 11.13 | 21.86 | 20.37 | 20.33 | 15.60 | 16.06 |
| EPS (₹) | 142.04 | 179.78 | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
| Dividend per share (₹) | 123.00 | 117.00 | 167.00 | 570.00 | 490.00 | 365.00 | 349.00 |
| Book value per share (₹) | 325.74 | 374.17 | 441.52 | 554.70 | 967.65 | 921.30 | 1,061.87 |
Web traffic of Allergy Free
The website of Allergy Free (allergyfree.co.in) receives about 13.9K visits a month.
- Monthly visits13.9K
▼ 25% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Allergy Free
Complete news archive for Allergy Free
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allergy Free
Allergy Free was founded in 2018.
Allergy Free is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Allergy Free has 2,191 employees.
The primary company behind Allergy Free, Sanofi India Limited, reported revenue of ₹1,857 Cr for FY 2025, down 9% year on year.
Allergies are discussed extensively on the website, covering symptoms, prevention strategies, and side effects across various types such as outdoor, indoor, and childhood allergies. Information on pollution-related risks in India and comparisons with conditions like COVID-19 is included to clarify distinctions. Management techniques, including lifestyle adjustments and diagnostic tools, are outlined to aid in symptom control, while myths and facts are addressed to promote accurate understanding. Resources like FAQs and downloads are made available for comprehensive support.
Allergy Free offers Allergy Information Services and Educational Resources.
Yes, Allergy Free is publicly traded on NSE under the ticker symbol SANOFI.
Allergy Free operates through Sanofi India Limited.
The legal entities of Allergy Free currently have 10 directors, including Vaibhav Vinayak Karandikar, Rahul Bhatnagar, Deepak Arora and others.
